Hypothalamic-pituitary-adrenal axis function in survivors of childhood acute lymphoblastic leukemia and healthy controls. 2012

Maartje S Gordijn, and Raphaele R van Litsenburg, and Reinoud J B J Gemke, and Marc B Bierings, and Peter M Hoogerbrugge, and Peter M van de Ven, and Cobi J Heijnen, and Gertjan J L Kaspers
Department of Pediatrics, Division Oncology/Hematology, VU University Medical Center, Amsterdam, The Netherlands. ms.gordijn@vumc.nl

Of all malignancies in children, acute lymphoblastic leukemia (ALL) is the most common type. Since survival significantly improves over time, treatment-related side effects become increasingly important. Glucocorticoids play an important role in the treatment of ALL, but they may suppress the hypothalamic-pituitary-adrenal (HPA) axis. The duration of HPA axis suppression is not yet well defined. The present study aimed at assessing the function of the HPA axis by determining the cortisol awakening response (CAR) and the dexamethasone (DEX) suppression test in children that were treated for childhood ALL, compared to a healthy age and sex matched reference group. In addition, questionnaires regarding sleep, fatigue, depression and quality of life were completed by the children and their parents. Fourty-three survivors who finished their treatment for childhood ALL 37 (interquartile range 22-75) months before and 57 healthy controls were included. No differences in CAR were observed between ALL survivors and the reference group, but survivors of ALL had higher morning cortisol levels and an increased cortisol suppression in response to oral dexamethasone. Higher cortisol levels in childhood ALL survivors were associated with more fatigue and poorer quality of life. We conclude that the experience of a stressful life event in the past may have caused a long-term dysregulation of the HPA axis in childhood ALL survivors, as reflected in an increased cortisol production and an enhanced negative feedback mechanism.

UI MeSH Term Description Entries
D007030 Hypothalamo-Hypophyseal System A collection of NEURONS, tracts of NERVE FIBERS, endocrine tissue, and blood vessels in the HYPOTHALAMUS and the PITUITARY GLAND. This hypothalamo-hypophyseal portal circulation provides the mechanism for hypothalamic neuroendocrine (HYPOTHALAMIC HORMONES) regulation of pituitary function and the release of various PITUITARY HORMONES into the systemic circulation to maintain HOMEOSTASIS. Hypothalamic Hypophyseal System,Hypothalamo-Pituitary-Adrenal Axis,Hypophyseal Portal System,Hypothalamic-Pituitary Unit,Hypothalamic Hypophyseal Systems,Hypothalamic Pituitary Unit,Hypothalamo Hypophyseal System,Hypothalamo Pituitary Adrenal Axis,Portal System, Hypophyseal
D008016 Life Change Events Those occurrences, including social, psychological, and environmental, which require an adjustment or effect a change in an individual's pattern of living. Life Course,Life Crises,Life Crisis,Life Experiences,Course, Life,Crisis, Life,Event, Life Change,Experience, Life,Life Change Event,Life Courses,Life Experience
D008297 Male Males
D010912 Pituitary-Adrenal Function Tests Tests that evaluate the adrenal glands controlled by pituitary hormones. Function Test, Pituitary-Adrenal,Function Tests, Pituitary-Adrenal,Pituitary Adrenal Function Tests,Pituitary-Adrenal Function Test,Test, Pituitary-Adrenal Function,Tests, Pituitary-Adrenal Function
D010913 Pituitary-Adrenal System The interactions between the anterior pituitary and adrenal glands, in which corticotropin (ACTH) stimulates the adrenal cortex and adrenal cortical hormones suppress the production of corticotropin by the anterior pituitary. Pituitary Adrenal System,Pituitary-Adrenal Systems,System, Pituitary-Adrenal,Systems, Pituitary-Adrenal
D011788 Quality of Life A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral, social environment as well as health and disease. HRQOL,Health-Related Quality Of Life,Life Quality,Health Related Quality Of Life
D011795 Surveys and Questionnaires Collections of data obtained from voluntary subjects. The information usually takes the form of answers to questions, or suggestions. Community Survey,Nonrespondent,Questionnaire,Questionnaires,Respondent,Survey,Survey Method,Survey Methods,Surveys,Baseline Survey,Community Surveys,Methodology, Survey,Nonrespondents,Questionnaire Design,Randomized Response Technique,Repeated Rounds of Survey,Respondents,Survey Methodology,Baseline Surveys,Design, Questionnaire,Designs, Questionnaire,Methods, Survey,Questionnaire Designs,Questionnaires and Surveys,Randomized Response Techniques,Response Technique, Randomized,Response Techniques, Randomized,Survey, Baseline,Survey, Community,Surveys, Baseline,Surveys, Community,Techniques, Randomized Response
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.

Related Publications

Maartje S Gordijn, and Raphaele R van Litsenburg, and Reinoud J B J Gemke, and Marc B Bierings, and Peter M Hoogerbrugge, and Peter M van de Ven, and Cobi J Heijnen, and Gertjan J L Kaspers
October 2018, Endocrine-related cancer,
Maartje S Gordijn, and Raphaele R van Litsenburg, and Reinoud J B J Gemke, and Marc B Bierings, and Peter M Hoogerbrugge, and Peter M van de Ven, and Cobi J Heijnen, and Gertjan J L Kaspers
October 2006, Psychoneuroendocrinology,
Maartje S Gordijn, and Raphaele R van Litsenburg, and Reinoud J B J Gemke, and Marc B Bierings, and Peter M Hoogerbrugge, and Peter M van de Ven, and Cobi J Heijnen, and Gertjan J L Kaspers
July 2022, Clinical endocrinology,
Maartje S Gordijn, and Raphaele R van Litsenburg, and Reinoud J B J Gemke, and Marc B Bierings, and Peter M Hoogerbrugge, and Peter M van de Ven, and Cobi J Heijnen, and Gertjan J L Kaspers
November 1999, Chest,
Maartje S Gordijn, and Raphaele R van Litsenburg, and Reinoud J B J Gemke, and Marc B Bierings, and Peter M Hoogerbrugge, and Peter M van de Ven, and Cobi J Heijnen, and Gertjan J L Kaspers
January 2009, Neuroimmunomodulation,
Maartje S Gordijn, and Raphaele R van Litsenburg, and Reinoud J B J Gemke, and Marc B Bierings, and Peter M Hoogerbrugge, and Peter M van de Ven, and Cobi J Heijnen, and Gertjan J L Kaspers
December 2022, Psycho-oncology,
Maartje S Gordijn, and Raphaele R van Litsenburg, and Reinoud J B J Gemke, and Marc B Bierings, and Peter M Hoogerbrugge, and Peter M van de Ven, and Cobi J Heijnen, and Gertjan J L Kaspers
March 2008, Pediatric blood & cancer,
Maartje S Gordijn, and Raphaele R van Litsenburg, and Reinoud J B J Gemke, and Marc B Bierings, and Peter M Hoogerbrugge, and Peter M van de Ven, and Cobi J Heijnen, and Gertjan J L Kaspers
November 2017, The Cochrane database of systematic reviews,
Maartje S Gordijn, and Raphaele R van Litsenburg, and Reinoud J B J Gemke, and Marc B Bierings, and Peter M Hoogerbrugge, and Peter M van de Ven, and Cobi J Heijnen, and Gertjan J L Kaspers
July 2015, Hematology (Amsterdam, Netherlands),
Maartje S Gordijn, and Raphaele R van Litsenburg, and Reinoud J B J Gemke, and Marc B Bierings, and Peter M Hoogerbrugge, and Peter M van de Ven, and Cobi J Heijnen, and Gertjan J L Kaspers
June 2010, Biological psychiatry,
Copied contents to your clipboard!